Pivotal Phase 3 Study on Primary Hyperoxaluria Has High Quality Results
source: pixabay.com

Pivotal Phase 3 Study on Primary Hyperoxaluria Has High Quality Results

As seen in PR Newswire, researchers at the biopharmaceutical company OxThera AB have spent 52 weeks studying 25 patients with primary hyperoxaluria (PH), a rare disease that progressively damages the…

Continue Reading Pivotal Phase 3 Study on Primary Hyperoxaluria Has High Quality Results

UK Cystic Fibrosis Influencer Marc Cotterill Presents ‘Patient View’ Video at European Cystic Fibrosis Conference

Ahead of Cystic Fibrosis Week in the UK, 37-year-old Marc Cotterill, who lives with the disease, has given a video presentation to the European Cystic Fibrosis Conference on the theme…

Continue Reading UK Cystic Fibrosis Influencer Marc Cotterill Presents ‘Patient View’ Video at European Cystic Fibrosis Conference